longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Fortress Biotech

FBIO

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Fortress Biotech(FBIO) the Revenue is 18.72 M (+14.04%), Beat estimate;the EBIT is -10.01 M (+72.57%), Miss estimate;the EPS is -0.08 (-117.8%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.02B14.04%
0.02B11.50%
+0.00B2.54%
EBITMiss expectations
-0.01B72.57%
-0.00B86.62%
-0.01B14.05%
EPSExceed expectations
-0.08117.78%
-0.2144.44%
+0.120026.66%

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf